Polymorphic acetylation of arylamines and DNA-adduct formation
- PMID: 2134671
Polymorphic acetylation of arylamines and DNA-adduct formation
Abstract
Inbred mouse strains congenic for rapid and slow N-acetyltransferase (NAT) (A.B6, rapid and B6.A, slow) were used to separate the effect of the NAT polymorphism from the influence of other genetically polymorphic enzymes on DNA adduct formation induced by exposure to arylamine carcinogens. Adduct formation was measured by HPLC analysis of 32P-postlabeled nucleotides from DNA of the urinary bladder and liver. Acetylator phenotype was a significant determinant of DNA damage in females as slow acetylators had higher levels of bladder DNA adducts than rapids. This correlation was the reverse of that seen with liver DNA. Older mice (20-23 weeks) formed much higher bladder DNA adduct levels than young mice (7 week). The increase in bladder adduct formation with age was seen in both sexes of all mouse strains. The older male B6 mice showed a 26-fold increase in bladder adducts and the older females showed no more than a 2-fold increase. In addition, the older male B6 mice produced significant amounts of an unidentified, early eluting adduct peak. Biochemical studies of liver NAT and O-acetyltransferase (OAT) activities showed a direct correlation between the levels of liver 2-aminofluorene (AF) NAT activity and levels of liver DNA-adduct formation, but the role of OAT activity in adduct formation in the mouse remains unclear. These results indicate that the NAT phenotype, age and sex are all important determinants of arylamine-DNA adduct formation in mice.
Similar articles
-
Genetic control of acetyl coenzyme A-dependent arylamine N-acetyltransferase, hydrazine N-acetyltransferase, and N-hydroxy-arylamine O-acetyltransferase enzymes in C57BL/6J, A/J, AC57F1, and the rapid and slow acetylator A.B6 and B6.A congenic inbred mouse.Drug Metab Dispos. 1988 May-Jun;16(3):341-7. Drug Metab Dispos. 1988. PMID: 2900723
-
Hemoglobin adduct and hepatic- and urinary bladder-DNA adduct levels in rapid and slow acetylator Syrian inbred hamsters administered 2-aminofluorene.J Pharmacol Exp Ther. 1992 Feb;260(2):865-71. J Pharmacol Exp Ther. 1992. PMID: 1738128
-
2-Aminofluorene-DNA adduct levels in tumor-target and nontarget organs of rapid and slow acetylator Syrian hamsters congenic at the NAT2 locus.Toxicol Appl Pharmacol. 1996 Nov;141(1):248-55. doi: 10.1006/taap.1996.0281. Toxicol Appl Pharmacol. 1996. PMID: 8917697
-
Cytochrome P-450 and acetyltransferase expression as biomarkers of carcinogen-DNA adduct levels and human cancer susceptibility.Prog Clin Biol Res. 1996;395:109-40. Prog Clin Biol Res. 1996. PMID: 8895986 Review.
-
Carcinogenic aromatic amine metabolism and DNA adduct detection in humans.Princess Takamatsu Symp. 1990;21:329-38. Princess Takamatsu Symp. 1990. PMID: 2134686 Review.